Sequence-Specific DNA Binders for the Therapy of Mitochondrial Diseases

The author's research focuses on developing sequence-specific DNA binders for the therapy of mitochondrial diseases. The developed compounds, called MITO-PIPs, recognize specific sequences in mitochondrial DNA and can reduce the copy number of mutated mitochondrial DNA in live cells. Tri-arginine vectors can enhance nuclear uptake of PIPs and improve their biological activity. This work paves the way for a transgene-free chemical gene therapy for mitochondrial diseases.

Format: Paperback / softback
Length: 94 pages
Publication date: 05 January 2023
Publisher: Springer Verlag, Singapore

This book delves into the author's groundbreaking work in developing sequence-specific DNA binders for the treatment of mitochondrial diseases. In the opening chapter, the author provides a comprehensive background on pyrrole–imidazole polyamides (PIPs) and mitochondrial disease research, paving the way for subsequent chapters that showcase the author's own research and discoveries.

The author introduces the concept of MITO-PIPs, compounds specifically designed to recognize and bind to specific sequences in mitochondrial DNA. The following chapter showcases the remarkable ability of MITO-PIPs to reduce the copy number of mutated mitochondrial DNA in live cells. By incorporating a DNA alkylating reagent into a MITO-PIP that recognizes the adjacent sequence to a target mutation, the author achieves a successful reduction in the mutated DNA.

Recognizing the importance of targeting nuclear DNA as well for treating mitochondrial diseases, the author demonstrates the use of tri-arginine vectors to enhance the nuclear uptake of PIPs and improve their biological activity in cells. This groundbreaking work holds significant promise for the development of a transgene-free chemical gene therapy for mitochondrial disorders.

The book is meticulously detailed, providing a comprehensive description of experimental procedures, particularly compound synthesis. This detailed account aids readers in gaining a clear understanding of the author's studies and empowers them to conduct similar and extended research endeavors.

Overall, this book is a valuable resource for researchers and clinicians interested in exploring innovative approaches to treating mitochondrial diseases. The author's groundbreaking work in developing sequence-specific DNA binders holds the potential to revolutionize the field of mitochondrial medicine.

Weight: 180g
Dimension: 235 x 155 (mm)
ISBN-13: 9789811684388
Edition number: 1st ed. 2022